In collaboration with BioNTech, Pfizer Company asked the Food and Drug Administration to approve their controversial experimental show that they call vaccine for children at the age of five to eleven.
The New York Times reported that the agency promised to analyze the request and tentatively scheduled a meeting on October 26, 2021. The ruling is expected to be announced between Halloween and Thanksgiving!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against Covid-19,” Pfizer said in a statement on Thursday.
The NY Times report moved on, saying that Pfizer gives the children one-third of the dosage for adults. It may ask more diluent to each injection or usage of a different vial or syringe.
The company has to explain and describe the method they plan to use in its submission to the Food and Drug Administration.
About 125 children in this age group died as a complication due to Covid-19.